✦ LIBER ✦

Biweekly cetuximab and irinotecan in advanced colorectal cancer patients progressing after at least one previous line of chemotherapy: results of a phase II single institution trial

✍ Scribed by Martín-Martorell, P; Roselló, S; Rodríguez-Braun, E; Chirivella, I; Bosch, A; Cervantes, A

Book ID: 109999624
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 97 KB
Volume: 99
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6604530

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vinflunine: a new active drug for second

Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy

✍ Campone, M; Cortes-Funes, H; Vorobiof, D; Martin, M; Slabber, C F; Ciruelos, E; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB

Vorinostat in advanced prostate cancer p

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862) : Trial results and interleukin-6 analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium

✍ Deborah Bradley; Dana Rathkopf; Rodney Dunn; Walter M. Stadler; Glenn Liu; David 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views